Download the notification: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of Twenty Three (23) formulations under the Drugs (Prices Control) Order, 2013, vide notification S.O. 1782 (E) dated 12-04-2022.

Click here to download the notification S.O. 1782(E) dated 12-04-2022

NPPA, in its order on April, 12, listed the Twenty Three (23) formulations for which it has fixed retail prices. A list of the formulations has been given below:

Click for more articles on NPPA

Formulations:

Click for more articles on DPCO

(a) The manufacturer of above mentioned formulations i.e. ―new drug‖ under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.

Must read

Latest notifications – DPCO /NPPA

FAQs – On DPCO: Drugs (Prices Control) Order, 2013

NPPA notifies revised ceiling price for 872 dosage forms: March 2022

NPPA fixes retail price of 19 formulations: February 2022

NPPA fixes retail price of 2 formulations: December 2021

NPPA fixes retail price of 28 formulations: December 2021

NPPA fixes retail price of 20 formulations: December 2021

NPPA fixes retail price of 2 formulations: November 2021

FDA warns websites illegally selling Amphetamine and Dextroamphetamine

16 Pharma units get ‘stop production orders’ for norm violations

Changes in Pharma Licensing: A tour

USFDA gives approval to Aleor for Lidocaine & Prilocaine cream

DCGI approves Glenmark’s phase-I clinical trial for its novel molecule GRC 54276

Moderna recalls thousands of C-19 vaccine doses

USFDA gives Zero Observations to SMS Lifesciences

NPPA fixes ceiling price of these two vaccines

Online दवा बिक्री पर रोक लगाए सरकार, CAIT ने लगाई मंत्रियों से गुहार: Must read

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/04/14/nppa-fixes-retail-price-of-23-formulations-april-2022/